Clinical Trials Browser

Phase 2 × Sunitinib × Tumor-Agnostic × Clear all

NCT02142036 2019-03-13

MetAction

Phase 2 Completed

Neoplasm Metastasis

NCT01020630 2014-05-14

SUN-CASE

Phase 2 Completed

Adenocarcinoma

NCT00137423 2009-09-30

Study Of SU011248 (Sunitinib) Given In A Continuous Daily Regimen In Patients With Advanced Renal Cell Cancer

Phase 2 Completed

107 enrolled 15 charts

Carcinoma